403 related articles for article (PubMed ID: 26876475)
41. Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomography.
Ginovart N; Galineau L; Willeit M; Mizrahi R; Bloomfield PM; Seeman P; Houle S; Kapur S; Wilson AA
J Neurochem; 2006 May; 97(4):1089-103. PubMed ID: 16606355
[TBL] [Abstract][Full Text] [Related]
42. Asymmetry in dopamine D(2/3) receptors of caudate nucleus is lost with age.
Vernaleken I; Weibrich C; Siessmeier T; Buchholz HG; Rösch F; Heinz A; Cumming P; Stoeter P; Bartenstein P; Gründer G
Neuroimage; 2007 Feb; 34(3):870-8. PubMed ID: 17174574
[TBL] [Abstract][Full Text] [Related]
43. Dopamine D
Khodaii J; Nomura Y; Chang NHS; Wong DF; Møller A; Gjedde A
Neurochem Res; 2023 May; 48(5):1517-1530. PubMed ID: 36525123
[TBL] [Abstract][Full Text] [Related]
44. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
[TBL] [Abstract][Full Text] [Related]
45. Nigrostriatal and Mesolimbic D
Stark AJ; Smith CT; Lin YC; Petersen KJ; Trujillo P; van Wouwe NC; Kang H; Donahue MJ; Kessler RM; Zald DH; Claassen DO
J Neurosci; 2018 Mar; 38(13):3230-3239. PubMed ID: 29483278
[TBL] [Abstract][Full Text] [Related]
46. Associations between dopamine D2 receptor availability and BMI depend on age.
Dang LC; Samanez-Larkin GR; Castrellon JJ; Perkins SF; Cowan RL; Zald DH
Neuroimage; 2016 Sep; 138():176-183. PubMed ID: 27208860
[TBL] [Abstract][Full Text] [Related]
47. Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy.
Tziortzi AC; Searle GE; Tzimopoulou S; Salinas C; Beaver JD; Jenkinson M; Laruelle M; Rabiner EA; Gunn RN
Neuroimage; 2011 Jan; 54(1):264-77. PubMed ID: 20600980
[TBL] [Abstract][Full Text] [Related]
48. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study.
Boileau I; Payer D; Houle S; Behzadi A; Rusjan PM; Tong J; Wilkins D; Selby P; George TP; Zack M; Furukawa Y; McCluskey T; Wilson AA; Kish SJ
J Neurosci; 2012 Jan; 32(4):1353-9. PubMed ID: 22279219
[TBL] [Abstract][Full Text] [Related]
49. Innately low D2 receptor availability is associated with high novelty-seeking and enhanced behavioural sensitization to amphetamine.
Tournier BB; Steimer T; Millet P; Moulin-Sallanon M; Vallet P; Ibañez V; Ginovart N
Int J Neuropsychopharmacol; 2013 Sep; 16(8):1819-34. PubMed ID: 23574629
[TBL] [Abstract][Full Text] [Related]
50. Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [(11)C]-(+)-PHNO.
Girgis RR; Slifstein M; D'Souza D; Lee Y; Periclou A; Ghahramani P; Laszlovszky I; Durgam S; Adham N; Nabulsi N; Huang Y; Carson RE; Kiss B; Kapás M; Abi-Dargham A; Rakhit A
Psychopharmacology (Berl); 2016 Oct; 233(19-20):3503-12. PubMed ID: 27525990
[TBL] [Abstract][Full Text] [Related]
51. The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: a clinical [11C]-(+)-PHNO PET study.
Graff-Guerrero A; Mizrahi R; Agid O; Marcon H; Barsoum P; Rusjan P; Wilson AA; Zipursky R; Kapur S
Neuropsychopharmacology; 2009 Mar; 34(4):1078-86. PubMed ID: 18987627
[TBL] [Abstract][Full Text] [Related]
52. Reward motivation in humans and its relationship to dopamine D
Caravaggio F; Fervaha G; Browne CJ; Gerretsen P; Remington G; Graff-Guerrero A
J Psychopharmacol; 2018 Mar; 32(3):357-366. PubMed ID: 29442593
[TBL] [Abstract][Full Text] [Related]
53. The relationship between excitement symptom severity and extrastriatal dopamine D
Joo YH; Kim JH; Son YD; Kim HK; Shin YJ; Lee SY; Kim JH
Eur Arch Psychiatry Clin Neurosci; 2018 Sep; 268(6):529-540. PubMed ID: 28623450
[TBL] [Abstract][Full Text] [Related]
54. Dopamine D3 receptor binding of (18)F-fallypride: Evaluation using in vitro and in vivo PET imaging studies.
Mukherjee J; Constantinescu CC; Hoang AT; Jerjian T; Majji D; Pan ML
Synapse; 2015 Dec; 69(12):577-91. PubMed ID: 26422464
[TBL] [Abstract][Full Text] [Related]
55. Differential regional decline in dopamine receptor availability across adulthood: Linear and nonlinear effects of age.
Seaman KL; Smith CT; Juarez EJ; Dang LC; Castrellon JJ; Burgess LL; San Juan MD; Kundzicz PM; Cowan RL; Zald DH; Samanez-Larkin GR
Hum Brain Mapp; 2019 Jul; 40(10):3125-3138. PubMed ID: 30932295
[TBL] [Abstract][Full Text] [Related]
56. Chronic Back Pain Is Associated with Alterations in Dopamine Neurotransmission in the Ventral Striatum.
Martikainen IK; Nuechterlein EB; Peciña M; Love TM; Cummiford CM; Green CR; Stohler CS; Zubieta JK
J Neurosci; 2015 Jul; 35(27):9957-65. PubMed ID: 26156996
[TBL] [Abstract][Full Text] [Related]
57. Mathematical modelling of [¹¹C]-(+)-PHNO human competition studies.
Searle GE; Beaver JD; Tziortzi A; Comley RA; Bani M; Ghibellini G; Merlo-Pich E; Rabiner EA; Laruelle M; Gunn RN
Neuroimage; 2013 Mar; 68():119-32. PubMed ID: 23207573
[TBL] [Abstract][Full Text] [Related]
58. Alteration of dopamine D2/D3 receptor binding in patients with juvenile myoclonic epilepsy.
Landvogt C; Buchholz HG; Bernedo V; Schreckenberger M; Werhahn KJ
Epilepsia; 2010 Sep; 51(9):1699-706. PubMed ID: 20384765
[TBL] [Abstract][Full Text] [Related]
59. Brain imaging of 18F-fallypride in normal volunteers: blood analysis, distribution, test-retest studies, and preliminary assessment of sensitivity to aging effects on dopamine D-2/D-3 receptors.
Mukherjee J; Christian BT; Dunigan KA; Shi B; Narayanan TK; Satter M; Mantil J
Synapse; 2002 Dec; 46(3):170-88. PubMed ID: 12325044
[TBL] [Abstract][Full Text] [Related]
60. Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D
Pfeifer P; Tüscher O; Buchholz HG; Gründer G; Vernaleken I; Paulzen M; Zimmermann US; Maus S; Lieb K; Eggermann T; Fehr C; Schreckenberger M
Addict Biol; 2017 Sep; 22(5):1449-1458. PubMed ID: 27396374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
